Peng, Haoning https://orcid.org/0000-0003-1388-3255
Wang, Zhile https://orcid.org/0000-0001-6820-8383
Wang, Mengyao https://orcid.org/0000-0002-1186-1792
Ding, Zheyu https://orcid.org/0009-0002-9560-0369
Li, Kaixiu
Wang, Yuqing
Yu, Xuejiao
Song, Siyang
Deng, Yulan
Liu, Yi
Pu, Qiang
Li, Lu
Cerezo, Michael https://orcid.org/0000-0002-3687-2009
Wang, Weiya
Liu, Lunxu
Shen, Shensi https://orcid.org/0000-0002-5087-8220
Funding for this research was provided by:
National Natural Science Foundation of China (82473387)
National Clinical Research Center for Geriatrics, West China hospital, Sichuan University
Article History
Received: 4 May 2025
Accepted: 11 February 2026
First Online: 24 February 2026
Competing interests
: The authors declare the following competing interests: S. Shen reports personal fees from Agence nationale de la recherche (France), Krebsliga Schweiz (Switzerland), KWF Kankerbestrijding (Netherlands), Austrian Research Funding, Belgian Foundation against Cancer, Shenzhen Medical Academy of Research and Translation (China), and serving as an Associate Editor for Oncogenesis (Springer Nature, London, UK); M. Cerezo is a CSO for BiPer Therapeutics (Strasbourg, France) and reports personal fees from European Commission. The remaining authors declare no competing interests.